Herbas VPB

Print
EN | LT
LT - REVERSIBLE COVALENT PYRROLO- OR PYRAZOLOPYRIMIDINES USEFUL FOR THE TREATMENT OF CANCER AND AUTOIMMUNE DISEASES
EN - REVERSIBLE COVALENT PYRROLO- OR PYRAZOLOPYRIMIDINES USEFUL FOR THE TREATMENT OF CANCER AND AUTOIMMUNE DISEASES

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 487/04
A61K 31/519
A61P 35/00
A61P 37/06
European patent
(11) Number of the document 2861599
(13) Kind of document T
(96) European patent application number 13731218.7
Date of filing the European patent application 2013-06-11
(97) Date of publication of the European application 2015-04-22
(45) Date of publication and mention of the grant of the patent 2019-12-18
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2013/045266
Date 2013-06-11
PCT application publication
(87) Number WO 2013/191965
Date 2013-12-27
Priority applications
(30) Number Date Country code
201261661203 P 2012-06-18 US
Inventors
(72)
GOLDSTEIN, David Michael, US
BERNER, Bret, US
Grantee
(73) Principia Biopharma Inc., 220 E. Grand Ave., S. San Francisco, CA 94080, US
Title
(54) REVERSIBLE COVALENT PYRROLO- OR PYRAZOLOPYRIMIDINES USEFUL FOR THE TREATMENT OF CANCER AND AUTOIMMUNE DISEASES
  REVERSIBLE COVALENT PYRROLO- OR PYRAZOLOPYRIMIDINES USEFUL FOR THE TREATMENT OF CANCER AND AUTOIMMUNE DISEASES
Last update date 2021-04-30